I agree that this site is using cookies. You can find further informations here.
X
Bellone, Stefania
273  results:
Search for persons X
?
1

Preclinical in vitro and in vivo activity of the RAF/MEK cl..:

Demirkiran, Cem ; Greenman, Michelle ; Bellone, Stefania...
Gynecologic Oncology.  187 (2024)  - p. 12-20 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Correction: Randomised phase II trial of weekly ixabepilone..:

Roque, Dana M. ; Siegel, Eric R. ; Buza, Natalia...
British Journal of Cancer.  130 (2024)  6 - p. 1073-1073 , 2024
Link: https://doi.org/10.1038/..
 
?
3

Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibod..:

Mutlu, Levent ; McNamara, Blair ; Bellone, Stefania...
Clinical & Experimental Metastasis.  , 2024
Link: https://doi.org/10.1007/..
 
?
4

Increased von Willebrand and Factor VIII plasma levels in g..:

Bellone, Stefania ; Siegel, Eric R. ; Scheim, David E..
Gynecologic Oncology Reports.  51 (2024)  - p. 101324 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Preclinical efficacy of RAF/MEK clamp avutometinib in combi..:

McNamara, Blair ; Demirkiran, Cem ; Hartwich, Tobias Max Philipp...
Gynecologic Oncology.  183 (2024)  - p. 133-140 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Sacituzumab govitecan in heavily pretreated, platinum-resis..:

Greenman, Michelle ; Bellone, Stefania ; Demirkiran, Cem..
Gynecologic Oncology Reports.  54 (2024)  - p. 101459 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Randomized phase II trial of weekly ixabepilone ± biweekly ..:

Roque, Dana M. ; Siegel, Eric R. ; Buza, Natalia...
BJC Reports.  2 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
8

Integrated mutational landscape analysis of poorly differen..:

Bellone, Stefania ; Jeong, Kyungjo ; Halle, Mari Kyllesø...
Proceedings of the National Academy of Sciences.  121 (2024)  17 - p. , 2024
Link: https://doi.org/10.1073/..
 
?
9

Preclinical activity of datopotamab deruxtecan, a novel TRO..:

McNamara, Blair ; Greenman, Michelle ; Bellone, Stefania...
Gynecologic Oncology.  189 (2024)  - p. 16-23 , 2024
Link: https://doi.org/10.1016/..
 
?
10

Elimusertib (BAY1895344), a novel ATR inhibitor, demonstrat..:

Harold, Justin ; Bellone, Stefania ; Manavella, Diego D....
Gynecologic Oncology.  168 (2023)  - p. 157-165 , 2023
Link: https://doi.org/10.1016/..
 
?
11

The Poly (ADP-ribose) polymerase inhibitor olaparib and pan..:

Han, Chanhee ; McNamara, Blair ; Bellone, Stefania...
Gynecologic Oncology.  170 (2023)  - p. 172-178 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Uterine leiomyosarcomas harboring MAP2K4 gene amplification..:

McNamara, Blair ; Harold, Justin ; Manavella, Diego...
Gynecologic Oncology.  172 (2023)  - p. 65-71 , 2023
Link: https://doi.org/10.1016/..
 
?
13

Pembrolizumab and lenvatinib in recurrent ovarian clear cel..:

McNamara, Blair ; Bellone, Stefania ; Demirkiran, Cem..
Gynecologic Oncology Reports.  48 (2023)  - p. 101218 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibod..:

Mauricio, Dennis ; Bellone, Stefania ; Mutlu, Levent...
Gynecologic Oncology.  170 (2023)  - p. 38-45 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Trastuzumab deruxtecan in recurrent uterine serous carcinom..:

McNamara, Blair ; Bellone, Stefania ; Demirkiran, Cem..
Gynecologic Oncology Reports.  48 (2023)  - p. 101219 , 2023
Link: https://doi.org/10.1016/..
 
1-15